Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Mesía
R
R
Department of Medical Oncology, Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain.
Rivera
F
F
Medical Oncology Department, Marqués de Valdecilla University Hospital, Santander, Spain.
Kawecki
A
A
Head and Neck Cancer Department, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Rottey
S
S
Medical Oncology, Ghent University Hospital, Ghent, Belgium.
Hitt
R
R
Medical Oncology Department, University Hospital '12 de Octubre', Madrid, Spain.
Kienzer
H
H
3rd Medical Department, Kaiser Franz Josef Spital, Ludwig Boltzmann Institute for Applied Cancer Research, Vienna, Austria.
Cupissol
D
D
Department of Medical Oncology, Val d'Aurelle-Paul Lamarque Regional Cancer Centre, Montpellier, France.
De Raucourt
D
D
Head and Neck Unit, François Baclesse Centre, Caen, France.
Benasso
M
M
Oncology Department, San Paolo Hospital, Savona Italy.
Koralewski
P
P
Oncology, Rydygier Memorial Hospital, Krakow-Nowa Huta, Poland.
Delord
J-P
JP
Department of Medical Oncology, Claudius Regaud Institute, Toulouse, France.
Bokemeyer
C
C
Department of Oncology, Hematology, BMT with section Pneumology, Hubertus Wald Tumorzentrum, University Cancer Center Hamburg, University Hospital, Hamburg, Germany.
Curran
D
D
Statistics, OMEGA Research, Santry, Dublin, Ireland.
Gross
A
A
Global Statistics, Merck KGaA, Darmstadt, Germany.
Vermorken
J B
JB
Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium. Electronic address: jan.b.vermorken@uza.be.